These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 25727587)
1. Periocular skin hyperpigmentation in children treated with prostaglandin analogues. Al-Zobidi M; Khandekar R; Craven ER; Hanafi S; Edward DP J AAPOS; 2015 Feb; 19(1):49-53. PubMed ID: 25727587 [TBL] [Abstract][Full Text] [Related]
2. Periocular mexametric melanin and erythema indexes in adult glaucoma patients treated with topical prostaglandin analogs. Duman N; Duman R; Yavaş GF; Doğruk Kaçar S; Özuğuz P; Çetinkaya E Cutan Ocul Toxicol; 2017 Mar; 36(1):9-11. PubMed ID: 26911512 [TBL] [Abstract][Full Text] [Related]
3. Prostaglandin-Associated Periorbitopathy in Children and Young Adults with Glaucoma. Kim JS; Blizzard S; Woodward JA; Leyngold IM; Liss J; Freedman SF Ophthalmol Glaucoma; 2020; 3(4):288-294. PubMed ID: 33008561 [TBL] [Abstract][Full Text] [Related]
4. Unilateral Prostaglandin-Associated Periorbitopathy: A Syndrome Involving Upper Eyelid Retraction Distinguishable From the Aging Sunken Eyelid. Rabinowitz MP; Katz LJ; Moster MR; Myers JS; Pro MJ; Spaeth GL; Sharma P; Stefanyszyn MA Ophthalmic Plast Reconstr Surg; 2015; 31(5):373-8. PubMed ID: 25393907 [TBL] [Abstract][Full Text] [Related]
5. The Association of Chronic Topical Prostaglandin Analog Use With Meibomian Gland Dysfunction. Mocan MC; Uzunosmanoglu E; Kocabeyoglu S; Karakaya J; Irkec M J Glaucoma; 2016 Sep; 25(9):770-4. PubMed ID: 27513901 [TBL] [Abstract][Full Text] [Related]
6. Eyelid and eyelash changes due to prostaglandin analog therapy in unilateral treatment cases. Yoshino T; Fukuchi T; Togano T; Seki M; Ikegaki H; Abe H Jpn J Ophthalmol; 2013 Mar; 57(2):172-8. PubMed ID: 23208023 [TBL] [Abstract][Full Text] [Related]
9. Pretarsal skin height changes in children receiving topical prostaglandin analogue therapy for primary congenital glaucoma. Al-Zobidi M; Khandekar R; Cruz A; Craven RE; Souru C; Malik R; Edward DP J AAPOS; 2018 Aug; 22(4):290-293.e1. PubMed ID: 29792934 [TBL] [Abstract][Full Text] [Related]
10. Periocular changes in topical bimatoprost and latanoprost use. Karslioğlu MZ; Hoşal MB; Tekeli O Turk J Med Sci; 2015; 45(4):925-30. PubMed ID: 26422869 [TBL] [Abstract][Full Text] [Related]
11. Prevention of dermatologic side effects of bimatoprost 0.03% topical therapy. Centofanti M; Oddone F; Chimenti S; Tanga L; Citarella L; Manni G Am J Ophthalmol; 2006 Dec; 142(6):1059-60. PubMed ID: 17157592 [TBL] [Abstract][Full Text] [Related]
12. A case of latanoprost-induced diffuse facial skin hyperpigmentation. Kim HY; Lee SK; Lee JH; Suh JH; Kim MS; Lee UH J Cosmet Dermatol; 2019 Dec; 18(6):1717-1720. PubMed ID: 30924263 [TBL] [Abstract][Full Text] [Related]
13. [Side-effects and risk profile of latanoprost 0.005% (Xalatan)]. Schlote T Ophthalmologe; 2002 Sep; 99(9):724-9. PubMed ID: 12219263 [TBL] [Abstract][Full Text] [Related]
14. The clinical impact and incidence of periocular pigmentation associated with either latanoprost or bimatoprost therapy. Sharpe ED; Reynolds AC; Skuta GL; Jenkins JN; Stewart WC Curr Eye Res; 2007 Dec; 32(12):1037-43. PubMed ID: 18085467 [TBL] [Abstract][Full Text] [Related]
15. Periocular discoloration after using a prostaglandin analog for eyelash enhancement: evaluation with reflectance confocal microscopy. N Horváth O; Letulé V; Ruzicka T; Herzinger T; Goldscheider I; von Braunmühl T J Cosmet Dermatol; 2017 Mar; 16(1):18-20. PubMed ID: 27595988 [TBL] [Abstract][Full Text] [Related]
16. Prostaglandin-Associated Periorbitopathy Symptom Alleviation After Switching Prostaglandin F Receptor Agonist to EP2 Receptor Agonist in Patients with Glaucoma. Sakata R; Fujishiro T; Saito H; Nakamura N; Honjo M; Shirato S; Miyamoto E; Yamada Y; Aihara M J Ocul Pharmacol Ther; 2023; 39(1):63-69. PubMed ID: 36318495 [No Abstract] [Full Text] [Related]
17. Latanoprost and periocular skin color changes. Wand M; Ritch R; Isbey EK; Zimmerman TJ Arch Ophthalmol; 2001 Apr; 119(4):614-5. PubMed ID: 11296032 [No Abstract] [Full Text] [Related]